Scarica l'app Stockscreener
4.70
11.32%
-0.60
Dopo l'orario di chiusura:
4.71
0.010
+0.21%
Precedente Chiudi:
$5.30
Aprire:
$5.02
Volume 24 ore:
185.21K
Relative Volume:
0.27
Capitalizzazione di mercato:
$11.33M
Reddito:
-
Utile/perdita netta:
$-22.71M
Rapporto P/E:
-0.4014
EPS:
-11.71
Flusso di cassa netto:
$-18.24M
1 W Prestazione:
-32.76%
1M Prestazione:
-51.02%
6M Prestazione:
-67.59%
1 anno Prestazione:
-95.35%
Intervallo 1D:
$4.6231
$5.1799
Intervallo di 1 settimana:
$4.6231
$7.19
Portata 52W:
$4.6231
$117.50
Genprex Inc Stock (GNPX) Company Profile
Nome
Genprex Inc
Settore
Industria
Telefono
512-537-7997
Indirizzo
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Confronta GNPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
4.70 | 11.33M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-26 | Iniziato | National Securities | Buy |
| 2019-04-29 | Iniziato | Noble Capital Markets | Outperform |
Genprex Inc Borsa (GNPX) Ultime notizie
Genprex (GNPX) Receives European Patent Intent for Cancer Gene T - GuruFocus
Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer - MarketScreener
Genprex Secures European Patent for Reqorsa® Therapy - TipRanks
Genprex to receive European patent for cancer gene therapy combination - Investing.com
Genprex Announces European Patent Intent for Reqorsa® Gene Therapy - TradingView
Is Genprex Inc. stock safe for conservative investors2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Genprex (NASDAQ: GNPX) gets EPO intent to grant patent for REQORSA+PD-1 in cancer - Stock Titan
Why Genprex Inc. stock remains a top recommendationEarnings Beat & AI Enhanced Trading Alerts - newser.com
Can Genprex Inc. (2DE0) stock stage a strong rebound this quarterMarket Sentiment Review & Long-Term Safe Return Strategies - newser.com
Analyzing drawdowns of Genprex Inc. with statistical toolsJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price target2025 Retail Activity & Safe Entry Point Alerts - newser.com
Will Genprex Inc. stock deliver consistent dividendsPortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com
Why Genprex Inc. stock remains undervaluedJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
Genprex Inc. stock retracement – recovery analysis2025 Top Gainers & Smart Allocation Stock Tips - newser.com
What technical models suggest about Genprex Inc.’s comebackJuly 2025 Review & High Conviction Investment Ideas - newser.com
How Genprex Inc. stock responds to policy changes2025 Big Picture & Low Risk Entry Point Tips - newser.com
Why Genprex Inc. stock is popular among millennialsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
How to integrate Genprex Inc. into portfolio analysis toolsPortfolio Update Report & Verified Chart Pattern Signals - newser.com
What indicators show strength in Genprex Inc.2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
Can Genprex Inc. (2DE0) stock sustain margin levels2025 Analyst Calls & Growth Focused Entry Reports - newser.com
Why analysts recommend Genprex Inc. (2DE0) stock2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Genprex Inc Azioni (GNPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):